Literature DB >> 22270908

Lysophosphatidylinositol stimulates [³⁵S]GTPγS binding in the rat prefrontal cortex and hippocampus.

Maria Luisa Rojo1, Antonio Rodriguez-Gaztelumendi, Christopher J Fowler.   

Abstract

Lysophosphatidylinositol (LPI) is a biologically active lipid that produces a number of responses in cultured cells, and has been suggested to have neuroprotective properties in vivo. Some of the actions of LPI are mediated by G-protein coupled receptors, but it is not known whether G-protein coupled receptor-mediated responses can be seen in intact brain tissue. In consequence, in the present study, we investigated autoradiographically whether LPI increased the [(35)S]GTPγS binding level in brain tissue slices. In standard assay conditions, where as a positive control a robust response to cannabinoid receptor activation by the agonist ligand CP55,940 was seen, there was no increase in the autoradiographic density over basal produced by LPI. However, when the conditions were modified (incubation at 4°C rather than at 25°C, incubation time increased to 3 h, GDP concentration reduced from 2 to 0.1 mM), a significant increase in [(35)S]GTPγS autoradiographic density in response to 10 μM LPI was seen in the prefrontal cortex, hippocampus, and cortex at the level of the hippocampus, although the degree of increase was small and very variable. No significant increases were seen in the hypothalamus or cerebellum. It is concluded that LPI, in the right conditions, can activate a sufficient number of G-proteins in the rat prefrontal cortex and hippocampus to produce a response in the [(35)S]GTPγS autoradiographic assay of G-protein coupled receptor function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270908     DOI: 10.1007/s11064-012-0704-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

Review 1.  An overview on functional receptor autoradiography using [35S]GTPgammaS.

Authors:  J Sóvágó; D S Dupuis; B Gulyás; H Hall
Journal:  Brain Res Brain Res Rev       Date:  2001-12

Review 2.  The [35S]GTPgammaS binding assay: approaches and applications in pharmacology.

Authors:  C Harrison; J R Traynor
Journal:  Life Sci       Date:  2003-12-12       Impact factor: 5.037

Review 3.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

4.  Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes.

Authors:  Karthika Singaravelu; Christian Lohr; Joachim W Deitmer
Journal:  J Neurosci       Date:  2006-09-13       Impact factor: 6.167

Review 5.  Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Julia Kargl; Clara Andradas; Andrew J Brown; Andrew Irving; Cristina Sanchez; Maria Waldhoer
Journal:  Mol Endocrinol       Date:  2011-09-29

6.  Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.

Authors:  Saori Oka; Shinji Kimura; Toshinobu Toshida; Ryo Ota; Atsushi Yamashita; Takayuki Sugiura
Journal:  J Biochem       Date:  2010-01-04       Impact factor: 3.387

7.  The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Lesley A Ford; Ruth A Ross; Maria Waldhoer; Andrew J Irving
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

8.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.

Authors:  L J Sim; D E Selley; S R Childers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.

Authors:  Ankur Kapur; Pingwei Zhao; Haleli Sharir; Yushi Bai; Marc G Caron; Larry S Barak; Mary E Abood
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

10.  Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.

Authors:  Yutaro Obara; Sanae Ueno; Yoshimi Yanagihata; Norimichi Nakahata
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

View more
  2 in total

1.  A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.

Authors:  Katrina Hurst; Corinne Badgley; Tanner Ellsworth; Spencer Bell; Lindsey Friend; Brad Prince; Jacob Welch; Zack Cowan; Ryan Williamson; Chris Lyon; Brandon Anderson; Brian Poole; Michael Christensen; Michael McNeil; Jarrod Call; Jeffrey G Edwards
Journal:  Hippocampus       Date:  2017-06-27       Impact factor: 3.899

2.  Role of GPR55 during Axon Growth and Target Innervation.

Authors:  Hosni Cherif; Anteneh Argaw; Bruno Cécyre; Alex Bouchard; Jonathan Gagnon; Pasha Javadi; Sébastien Desgent; Ken Mackie; Jean-François Bouchard
Journal:  eNeuro       Date:  2015-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.